Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 3576 - 3600 of 4207 in total
SNX-2112 is a heat shock protein 90 (Hsp90) inhibitor.
Investigational
Investigational
Eftansomatropin alfa (GX-H9) comprises a recombinant human growth hormone fused to hyFc, a synthetic hybrid Fc fragment. It is under investigation for the treatment of growth hormone deficiency.
Investigational
Mapatumumab is under investigation in clinical trial NCT00094848 (Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-hodgkin's Lymphoma (NHL)).
Investigational
Experimental
Dipropyl-4-hydroxytryptamine is the 4-hydroxyl analog of dipropyltryptamine (DPT). Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. This agent and its properties haven't been fully elucidated.
Experimental
Azoximer bromide is under investigation in clinical trial NCT04381377 (Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19).
Investigational
As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony stimulating factor (GM-CSF), a cytokine known to enhance vaccine efficacy through prolongation of humoral and cell immunity.
Investigational
Investigational
Investigational
(R)-Gossypol is the R-isomer of Gossypol.
Investigational
RGX-121 is designed to use the NAV AAV9 vector to deliver the human iduronate-2-sulfatase gene to the central nervous system.
Investigational
VO659 is an antisense oligonucleotide being investigated for the treatment of Huntington's disease.
Investigational
Investigational
Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.
Investigational
Matched Salts name: … Ozagrel Sodium
Displaying drugs 3576 - 3600 of 4207 in total